VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AJG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AJGArthur J. Gallagher & Co.
$254.67$65.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAJGQuarterly Financials

Arthur J. Gallagher & Co. (AJG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Arthur J. Gallagher & Co. (AJG) quarterly income statement — complete revenue, gross profit & net income history

AJG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue4.76B3.63B3.37B3.22B3.73B2.72B2.81B2.78B3.26B2.44B2.49B2.44B2.71B2.02B2.05B2.04B2.43B1.96B2.13B1.93B
Revenue Growth %27.65%33.58%19.91%16.05%14.45%11.41%12.63%13.66%20.35%20.79%21.84%19.69%11.18%2.82%-4.15%5.55%12.63%14.52%15.61%22.1%
Medical Costs & Claims720M2.21B316.5M1.85B1.94B1.59B1.66B1.66B1.76B1.47B1.46B1.45B1.45B1.21B1.21B1.2B1.34B1.27B1.4B1.24B
Medical Cost Ratio %15.13%60.89%9.4%57.32%51.96%58.56%59.22%59.79%54.18%60.18%58.7%59.3%53.53%59.86%59.35%58.61%54.88%64.95%65.57%64.29%
Gross Profit4.04B1.42B3.05B1.37B1.79B1.13B1.14B1.12B1.49B970.8M1.03B993.9M1.26B810.2M831.5M844.5M1.1B688M734.7M690.3M
Gross Margin %84.87%39.11%90.6%42.68%48.04%41.44%40.78%40.21%45.82%39.82%41.3%40.7%46.47%40.14%40.65%41.39%45.12%35.05%34.43%35.71%
Gross Profit Growth %125.5%26.07%166.39%23.17%20%15.95%11.22%12.27%18.67%19.82%23.76%17.69%14.5%17.76%13.18%22.34%30.15%19.34%20.17%20.3%
Operating Expenses2.82B1.08B2.51B750.1M743.8M651.9M663.7M637.2M643.4M640.3M594.7M609.3M541.9M522.2M467M464.2M477.1M466.8M396.9M398.6M
OpEx / Revenue %59.27%29.71%74.65%23.29%19.95%24%23.65%22.96%19.76%26.27%23.86%24.95%20.03%25.87%22.83%22.75%19.6%23.78%18.6%20.62%
Depreciation & Amortization339M362M276.3M230.8M253.4M213M210M211.6M207.7M189.7M171.7M175.7M159.4M154M145.5M140.3M159.8M146.5M131.3M145.2M
Combined Ratio %74.4%90.6%84.06%80.61%71.91%82.56%82.87%82.75%73.94%86.44%82.57%84.25%73.56%85.73%82.18%81.36%74.48%88.73%84.17%84.91%
Operating Income1.22B341M536.6M624.4M1.05B473.7M480.9M478.7M848.8M330.5M434.4M384.6M715.5M288M364.5M380.3M621.1M221.2M337.8M291.7M
Operating Margin %25.6%9.4%15.94%19.39%28.09%17.44%17.13%17.25%26.06%13.56%17.43%15.75%26.44%14.27%17.82%18.64%25.52%11.27%15.83%15.09%
Operating Income Growth %16.34%-28.01%11.58%30.44%23.34%43.33%10.7%24.47%18.63%14.76%19.18%1.13%15.2%30.2%7.9%30.37%32.88%4.24%23.15%23.39%
EBITDA1.56B703M812.9M855.2M1.3B686.7M690.9M690.3M1.06B520.2M606.1M560.3M874.9M442M510M520.6M780.9M367.7M469.1M436.9M
EBITDA Margin %32.72%19.38%24.15%26.55%34.88%25.28%24.62%24.87%32.44%21.34%24.32%22.95%32.33%21.9%24.94%25.52%32.08%18.73%21.98%22.6%
Interest Expense158M161M160.8M158.6M158.4M101.9M92.9M94.3M92.2M78.2M72.8M77.8M67.9M64M64.4M64.6M63.9M61.5M60.3M56.2M
Non-Operating Income17M028.9M-5.6M15.8M26M-15.3M18.8M-16.1M334.5M09.4M41.8M102M-14.9M-36.6M19.5M46.7M46.1M13.2M
Pretax Income1.04B180M346.9M471.4M872.7M333.2M403.3M365.6M772.7M-82.2M364.1M297.4M605.8M122M315M352.3M537.7M113M231.4M222.3M
Pretax Margin %21.92%4.96%10.31%14.64%23.41%12.27%14.37%13.17%23.73%-3.37%14.61%12.18%22.39%6.04%15.4%17.27%22.09%5.76%10.84%11.5%
Income Tax220M26M73.3M105.2M163.8M75M89.2M80.2M160M-42.6M80.9M61.6M119.2M-13.5M58.7M67.2M98.6M-7.9M-7.2M20.5M
Effective Tax Rate %21.09%14.44%21.13%22.32%18.77%22.51%22.12%21.94%20.71%51.82%22.22%20.71%19.68%-11.07%18.63%19.07%18.34%-6.99%-3.11%9.22%
Net Income822M151M272.7M365.8M704.4M258.3M312.6M283.4M608.4M-32.2M280.7M234.5M486.5M135.5M255.8M284.2M438.7M109.4M225.1M190.2M
Net Margin %17.28%4.16%8.1%11.36%18.9%9.51%11.14%10.21%18.68%-1.32%11.26%9.6%17.98%6.71%12.51%13.93%18.02%5.57%10.55%9.84%
Net Income Growth %16.7%-41.54%-12.76%29.08%15.78%902.17%11.36%20.85%25.06%-123.76%9.73%-17.49%10.9%23.86%13.64%49.42%14.81%-23.07%27.46%23.75%
EPS (Diluted)3.160.581.051.402.721.121.391.272.74-0.151.281.072.240.631.191.332.050.511.060.92
EPS Growth %16.18%-48.21%-24.46%10.24%-0.73%846.67%8.59%18.69%22.32%-123.81%7.56%-19.55%9.27%23.53%12.26%44.57%6.77%-29.17%17.78%16.46%
EPS (Basic)3.200.581.061.432.761.141.431.302.80-0.151.301.092.290.641.211.352.100.531.090.94
Diluted Shares Outstanding259.82M260.34M260.41M260.44M259.42M231.06M223.9M222.9M222M216.33M220.2M219M217M215.83M215M214.3M213.5M212.86M211.5M205.8M